Reporting of Clinical Trials: Should we adopt CONSORT Statement?

Authors

DOI:

https://doi.org/10.66344/jpad.13.2.2003.731

References

http://www.consort-statement.org (accessed 04/04/2003).

Moher D, Schulz KF, Altman D. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-91.

Downloads

Published

03.01.2017

Issue

Vol. 13 No. 2 (2003): April - June

Section

Editorial

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

How to Cite

1.
Reporting of Clinical Trials: Should we adopt CONSORT Statement?. J Pak Assoc Dermatol [Internet]. 2017 Jan. 3 [cited 2026 Jul. 26];13(2):52-4. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/731